Metabolic and bariatric surgery (MBS) is the most effective obesity treatment, though the mechanisms underlying its marked weight loss compared to dietary/behavioral approaches remain unclear. Despite its efficacy, however, weight regain can occur. Although weight regain can result from anatomic failure (e.g. gastro-gastric fistula), regain is typically multifactorial (e.g. environment, behavioral stressors, new diagnoses). Surgical treatment for weight regain is increasing1, but understanding weight regain physiology and how surgical treatment alters that physiology remains poorly understood. Better understanding of weight regain physiology and MBS treatments remains critically important.

To understand the role obesity contributes to COVID infection

To reveal whether patients who undergo bariatric surgery are at increased risk for developing a post-surgical cannabis use disorder and will also shed light on whether cannabis use affects post-surgical weight loss and medical comorbidities. To guide programmatic recommendations and monitoring to help optimize outcomes for patients pursuing bariatric surgery and to support future grant applications including identifying distal and proximal predictors of cannabis use, as well as, development of technology-based interventions to reduce substance use and problematic eating behaviors to optimize weight loss outcomes.

To reveal whether patients who undergo bariatric surgery are at increased risk for developing a post-surgical cannabis use disorder and will also shed light on whether cannabis use affects post-surgical weight loss and medical comorbidities. To guide programmatic recommendations and monitoring to help optimize outcomes for patients pursuing bariatric surgery and to support future grant applications including identifying distal and proximal predictors of cannabis use, as well as, development of technology-based interventions to reduce substance use and problematic eating behaviors to optimize weight loss outcomes.

To not only elucidate the immediate benefits of bariatric surgery in asthma but also achieve important insights that can better aid understanding of the mechanism by which these procedures improve the disease in obese patients.

To not only elucidate the immediate benefits of bariatric surgery in asthma but also achieve important insights that can better aid understanding of the mechanism by which these procedures improve the disease in obese patients.

Is gut microbiome involved in improvement of diabetes and NAFLD/NASH after RYGB and SG surgeries? Can change in the microbiome after RYGB and SG protect against diabetes and NAFLD/NASH in susceptible animals?

To conduct original research comparing bariatric robotic procedures against bariatric laparoscopic bariatric procedures and the effect on surgeon fatigue and discomfort.

To understand the metabolic and microbiome differences between obese patients with metabolic syndrome and healthy obese patients.

The liver plays a central role in obesity-induced insulin resistance and normalization of blood glucose in the immediate period following RYGB. We sought to understand the genetic pathways which underlie resolution of insulin resistance and blood glucose levels.

The liver plays a central role in obesity-induced insulin resistance and normalization of blood glucose in the immediate period following RYGB. We sought to understand the genetic pathways which underlie resolution of insulin resistance and blood glucose levels.

The objective of the study is to evaluate a newly developed Internet-delivered (via e-learning modules) acceptance-based behavioral intervention (ABTi) for individuals who are experiencing weight regain post-surgery. We are assessing ABTi’s efficacy on stopping and/or reversing weight by comparing it to a wait-list control (WLC) condition. We are also evaluating its effect on targeted weight control behaviors and acceptance-based skills. Finally, we are examining the relationship between weight outcomes and changes in process variables through exploratory analyses.

The objective of the study is to evaluate a newly developed Internet-delivered (via e-learning modules) acceptance-based behavioral intervention (ABTi) for individuals who are experiencing weight regain post-surgery. We are assessing ABTi’s efficacy on stopping and/or reversing weight by comparing it to a wait-list control (WLC) condition. We are also evaluating its effect on targeted weight control behaviors and acceptance-based skills. Finally, we are examining the relationship between weight outcomes and changes in process variables through exploratory analyses.

To understand the metabolic and microbiome differences between obese patients with metabolic syndrome and healthy obese patients.

To evaluate the importance of the gut hormone response to age-associated diabetes remission following the two most prevalent bariatric surgery procedures performed today, laparoscopic RYGB (LRYGB) and laparoscopic sleeve gastrectomy (SG).